Towa Pharmaceutical Co., Ltd. (OTCMKTS:TWAPF) Short Interest Update

Towa Pharmaceutical Co., Ltd. (OTCMKTS:TWAPF) was the recipient of a significant decrease in short interest in March. As of March 15th, there was short interest totalling 16,300 shares, a decrease of 68.1% from the February 28th total of 51,100 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days.

Towa Pharmaceutical Stock Performance

OTCMKTS TWAPF opened at $24.35 on Friday. The business’s 50 day moving average is $24.35 and its two-hundred day moving average is $24.35. Towa Pharmaceutical has a 12-month low of $24.35 and a 12-month high of $24.35.

Towa Pharmaceutical Company Profile

Towa Pharmaceutical Co, Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products.